✦ LIBER ✦

Process Research and Development for the Kilogram Manufacture of the SRC Kinase Inhibitor AZD0530

✍ Scribed by Ford, J. Gair; Pointon, Simon M.; Powell, Lyn; Siedlecki, Paul S.; Baum, John; Chubb, Richard; Fieldhouse, Robin; Muxworthy, James; Nivlet, Alex; Stenson, Rachel; Warwick, Eleanor

Book ID: 120914241
Publisher: American Chemical Society
Year: 2010
Tongue: English
Weight: 404 KB
Volume: 14
Category: Article
ISSN: 1083-6160
DOI: 10.1021/op100161y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

361 Preclinical activity of AZD0530, a n

361 Preclinical activity of AZD0530, a novel, oral, potent and selective inhibitor of the Src family kinases

✍ T.P. Green; M. Fennell; R. Whittaker; J. Curwen; V. Jacobs; J. Allen; P.A. Ple; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

First report of the safety, tolerability

First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours

✍ Yasuhito Fujisaka, Yusuke Onozawa, Takayasu Kurata, Hirofumi Yasui, Isao Goto, K 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 188 KB

EFFECT OF THE SPECIFIC SRC KINASE INHIBI

EFFECT OF THE SPECIFIC SRC KINASE INHIBITOR AZD0530 ON OSTEOLYTIC LESIONS IN PROSTATE CANCER

✍ Yang, Joy C; Bai, Lanfang; Kung, Hsing-Jien; Evans, Christopher P 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 125 KB

50 POSTER Inhibition of Src kinase with

50 POSTER Inhibition of Src kinase with the dual Src/Abl kinase inhibitor AZD0503 reduces bladder tumour growth and the development of mixed osteolytic/osteosclerotic lesions in bone

✍ E.D. Williams; E.W. Thompson; D. Sreedharan; T.P. Green 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Effects of the Src kinase inhibitor sara

Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial

✍ Rosemary A Hannon; Glen Clack; Martin Rimmer; Alan Swaisland; J Andrew Lockton; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 243 KB

Erratum: Effects of the Src kinase inhib

Erratum: Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial

✍ Rosemary A Hannon; Glen Clack; Martin Rimmer; Alan Swaisland; J Andrew Lockton; 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 31 KB